AngioDynamics (ANGO) Financials: Revenue & Earnings

ANGO price $12.09 -0.17 -1.39%

Ticker
ANGO
Price
$12.09
Change
-0.17 -1.39%
Market cap ?
$508.44M
P/E ?
-15.65
Forward P/E ?
54.95
Dividend yield ?
0.00%
Beta ?
0.30
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Stocklytics score
52
Value
46
Quality
39
Growth
71

Stocklytics score rationale: value 46, quality 39, growth 71.

Financials

2017201820192020202120222023202420252026
349643000344285000359484000264157000291010000316219000338752000303914000292498000320174000

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The…

Fair value

ANGO fair value $13.65. Price $12.09. Price is 11% below fair value.

Above fair value, and more expensive than usual. A larger premium than on 61% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 35.00M. Growth 5.55%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 42.05M. Net debt -53.86M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare ANGO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2027-01-06—-0.10—84.32M
2026-10-08-0.04-0.1180.92M80.51M
2026-07-14-0.07-0.1186.61M80.24M
2026-04-02-0.07-0.1178.42M76.77M
2026-01-06-0.15-0.1079.43M76.43M
2025-10-02-0.10-0.1475.71M76.31M
2025-07-15-0.03-0.1380.16M74.26M
2025-04-020.03-0.1372.00M74.26M
2025-01-08-0.04-0.1172.84M70.57M
2024-10-03-0.11-0.1567.49M67.93M
2024-07-16-0.06-0.2070.98M70.85M
2024-04-04-0.16-0.1475.18M75.73M
2024-01-05-0.05-0.0979.07M82.04M
2023-10-04-0.12-0.1478.68M77.69M
2023-07-120.020.0291.07M90.73M
2023-03-30-0.03-0.0180.71M91.16M
2023-01-050.010.0085.43M84.38M
2022-10-06-0.06-0.0281.54M83.43M
2022-07-120.010.0187.00M82.92M
2022-04-070.030.0173.97M76.32M
2022-01-06-0.02-0.0078.28M76.32M
2021-09-30-0.02-0.0576.97M71.31M
2021-07-13-0.51—76.84M72.68M
2021-03-300.020.0171.18M68.95M
2021-01-070.010.0072.77M163.73M
2020-09-290.02-0.0670.22M245.76M
2020-07-16-0.06-0.0558.33M58.33M
2020-04-070.010.0069.78M209.34M
2020-01-070.060.0270.00M23.33M
2019-10-030.080.0466.04M33.02M
2019-07-100.250.2696.30M7.75M
2019-04-020.190.2286.34M99.97M
2019-01-040.220.2191.50M87.34M
2018-09-270.160.1885.34M96.01M
2018-07-110.200.2188.32M92.73M
2018-03-290.250.2083.85M63.73M
2018-01-040.160.1786.71M86.71M
2017-09-280.120.1685.41M113.88M
2017-07-180.190.1686.91M73.19M
2017-03-300.190.1585.60M67.58M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-30Nighan Warren JRSell23.37K$14.72344.01K
2026-07-22Piccinini LauraBuy8.05K——
2026-07-22Piccinini LauraSell4.51K$13.8262.27K
2026-07-22Piccinini LauraSell28.34K——
2026-07-22Nighan Warren JRBuy5.69K——
2026-07-22Nighan Warren JRSell1.67K$13.8223.09K
2026-07-22Nighan Warren JRSell20.05K——
2026-07-22Trowbridge Stephen ABuy16.30K——
2026-07-22Trowbridge Stephen ASell8.32K$13.82114.97K
2026-07-22Trowbridge Stephen ASell57.38K——
2026-07-22Clemmer James CBuy52.36K——
2026-07-22Clemmer James CSell26.73K$13.82369.38K
2026-07-22Clemmer James CSell184.36K——
2026-07-22Campbell Chad ThomasBuy6.47K——
2026-07-22Campbell Chad ThomasSell2.33K$13.8232.20K
2026-07-22Campbell Chad ThomasSell22.77K——
2026-07-20Trowbridge Stephen ASell717$13.719.83K
2026-07-20Piccinini LauraSell616$13.718.45K
2026-07-20Nighan Warren JRSell251$13.713.44K
2026-07-20Clemmer James CSell4.22K$13.7157.90K
2026-07-20Campbell Chad ThomasSell359$13.714.92K
2026-07-19Clemmer James CSell11.76K$13.51158.93K
2026-07-19Clemmer James CSell487$13.516.58K
2026-07-17Trowbridge Stephen ASell3.51K$13.5147.42K
2026-07-17Piccinini LauraSell3.07K$13.5141.53K
2026-07-17Nighan Warren JRSell1.37K$13.5118.55K
2026-07-17Clemmer James CSell10.65K$13.51143.87K
2026-07-17Campbell Chad ThomasSell1.11K$13.5115.02K
2026-07-16Weiss Lawrence TSell2.27K$14.1432.06K
2026-07-16Trowbridge Stephen ASell7.84K$14.14110.86K
2026-07-16Piccinini LauraSell4.54K$14.1464.17K
2026-07-16Nighan Warren JRSell2.15K$14.1430.44K
2026-07-16Clemmer James CSell18.59K$14.14262.83K
2026-07-16Campbell Chad ThomasSell2.37K$14.1433.47K
2026-07-15REED JAN STERNBuy11.89K——
2026-07-15Licitra Karen ABuy11.89K——
2026-07-15JOHNSON WESLEYBuy11.89K——
2026-07-15DONNELLY HOWARD WBuy11.89K——
2026-07-15Burgess LorindaBuy11.89K——
2026-07-15Auen Eileen O'SheaBuy11.89K——
2026-07-15Tarnoff Michael EBuy11.89K——
2026-07-15Trowbridge Stephen ABuy53.26K——
2026-07-15Trowbridge Stephen ABuy53.26K——
2026-07-15Piccinini LauraBuy19.86K——
2026-07-15Piccinini LauraBuy19.86K——
2026-07-15Nighan Warren JRBuy17.97K——
2026-07-15Nighan Warren JRBuy17.97K——
2026-07-15Campbell Chad ThomasBuy16.08K——
2026-07-15Campbell Chad ThomasBuy16.08K——
2026-07-15Weiss Lawrence TBuy21.29K——
2026-07-15Weiss Lawrence TBuy21.29K——
2025-10-21Weiss Lawrence TBuy10.00K$11.81118.10K
2025-10-13Trowbridge Stephen ABuy890$11.169.93K
2025-10-09Clemmer James CBuy10.00K$11.15111.50K
2025-07-21Trowbridge Stephen ASell667$8.996.00K
2025-07-21Nighan Warren JRSell277$8.992.49K
2025-07-21Campbell Chad ThomasSell395$8.993.55K
2025-07-20Trowbridge Stephen ASell717$8.696.23K
2025-07-20Piccinini LauraSell616$8.695.35K
2025-07-20Nighan Warren JRSell251$8.692.18K
2025-07-20Clemmer James CSell2.98K$8.6925.91K
2025-07-20Clemmer James CSell3.67K$8.9933.02K
2025-07-20Campbell Chad ThomasSell359$8.693.12K
2025-07-19Trowbridge Stephen ASell2.58K$8.6922.46K
2025-07-19Piccinini LauraSell1.98K$8.6917.23K
2025-07-19Nighan Warren JRSell735$8.696.39K
2025-07-19Clemmer James CSell344$8.692.99K
2025-07-19Clemmer James CSell8.31K$8.6972.19K
2025-07-19Campbell Chad ThomasSell1.02K$8.698.91K
2025-07-17Piccinini LauraSell3.07K$8.7426.87K
2025-07-16Nighan Warren JRBuy29.35K——
2025-07-16Nighan Warren JRBuy29.35K——
2025-07-16Clemmer James CBuy206.25K——
2025-07-16Clemmer James CBuy206.25K——
2025-07-16Weiss Lawrence TBuy30.90K——
2025-07-16Weiss Lawrence TBuy30.90K——
2025-07-16Trowbridge Stephen ABuy87.00K——
2025-07-16Trowbridge Stephen ABuy87.00K——
2025-07-16Campbell Chad ThomasBuy26.27K——
2025-07-16Campbell Chad ThomasBuy26.27K——
2025-07-16DONNELLY HOWARD WBuy17.68K——
2025-07-16Piccinini LauraBuy32.42K——
2025-07-16Burgess LorindaBuy17.68K——
2025-07-16Piccinini LauraBuy32.42K——
2025-07-16Auen Eileen O'SheaBuy17.68K——
2025-07-16Tarnoff Michael EBuy17.68K——
2025-07-16REED JAN STERNBuy17.68K——
2025-07-16Licitra Karen ABuy17.68K——
2025-07-16JOHNSON WESLEYBuy17.68K——
2025-01-16Nighan Warren JRSell4.06K$12.3149.98K
2024-12-02Weiss Lawrence TBuy103.65K$7.14740.06K
2024-12-02Weiss Lawrence TBuy52.70K——
2024-12-02Weiss Lawrence TOther0——
2024-10-10Nighan Warren JRBuy100$6.08608
2024-10-08Trowbridge Stephen ABuy1.70K$5.869.96K
2024-10-07Nighan Warren JRBuy768$6.094.68K
2024-10-07Clemmer James CBuy20.00K$6.03120.60K
2024-07-21Campbell Chad ThomasSell395$7.132.82K
2024-07-21Piccinini LauraSell413$7.132.94K
2024-07-21Clemmer James CSell3.37K$7.1324.04K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 163, holders +12 vs prior quarter. Ownership 92.21%.

HolderSharesChangeChange %Value
BLACKROCK, INC.3.80M117.33K+3.18%49.48M
POINT72 ASSET MANAGEMENT, L.P.3.06M-119.31K-3.75%39.84M
SYSTEMATIC FINANCIAL MANAGEMENT LP2.64M186.51K+7.60%34.35M
ARMISTICE CAPITAL, LLC2.20M329.00K+17.60%28.60M
ROYCE & ASSOCIATES LP1.97M440.88K+28.84%25.63M
BROADFIN HOLDINGS LLC1.82M-250.80K-12.12%23.66M
VANGUARD CAPITAL MANAGEMENT LLC1.69M-32.10K-1.86%22.05M
WEBER CAPITAL MANAGEMENT LLC /ADV1.36M-16.55K-1.21%17.65M
NUVEEN, LLC1.20M-16.81K-1.38%15.60M
GEODE CAPITAL MANAGEMENT, LLC1.02M35.23K+3.58%13.28M
DIMENSIONAL FUND ADVISORS LP969.50K20.68K+2.18%12.61M
STATE STREET CORP958.17K-375.69K-28.17%12.47M
SEGALL BRYANT & HAMILL, LLC926.71K-39.25K-4.06%12.06M
BASTION ASSET MANAGEMENT INC.923.27K-389.73K-29.68%10.78M
PIER CAPITAL, LLC806.68K9.98K+1.25%10.49M
MILLENNIUM MANAGEMENT LLC783.12K138.45K+21.48%10.19M
RENAISSANCE TECHNOLOGIES LLC733.88K-69.40K-8.64%9.55M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP692.53K-65.92K-8.69%9.01M
PARADIGM CAPITAL MANAGEMENT INC/NY671.20K-47.00K-6.54%8.73M
AQR CAPITAL MANAGEMENT LLC589.16K337.64K+134.24%7.66M
ACADIAN ASSET MANAGEMENT LLC488.26K19.59K+4.18%6.34M
VANGUARD PORTFOLIO MANAGEMENT LLC440.84K4.36K+1.00%5.74M
MARSHALL WACE, LLP420.38K-65.13K-13.41%5.47M
WESTERN STANDARD LLC387.19K387.19KNew5.04M
GOLDMAN SACHS GROUP INC382.92K68.83K+21.91%4.98M

Earnings and financials

AngioDynamics, Inc. (ANGO) trades at $12.09, with a market cap of $508.44M and a trailing P/E of -15.65. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2017201820192020202120222023202420252026
349643000344285000359484000264157000291010000316219000338752000303914000292498000320174000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

AngioDynamics (ANGO) Financials: Revenue & Earnings

ANGO$12.09-0.17 -1.39%

$508.44M

Market Cap

-15.65

P/E

54.95

Forward P/E

52

Score

Price History